What To Know: The stock's movements could be fueled by investors interpreting the move as an alignment with the retail-driven, anti-short-selling movement.

Quantum explicitly framed the investment as part of its ongoing fight against market corruption and manipulative trading. This narrative is led by Board Advisor Kevin Malone, of Malone Wealth. Malone publicly cited GameStop's "extreme value" as a key reason for the purchase.

This action reinforces Quantum's established identity as an advocate against market manipulation. The company has recently appointed outspoken critics of naked short selling, such as Malone and Director Terry Lynch, and is actively pursuing a $700 million lawsuit against several financial institutions for alleged stock spoofing.

Quantum also points to its core business of advancing its Lucid-MS drug candidate for multiple sclerosis. The company says it is also enhancing shareholder value through a planned special dividend of Contingent Value Rights tied to litigation outcomes.

QNTM Price Action: According to data from Benzinga Pro, QNTM shares were up 0.25% to $22.50 on Wednesday afternoon. The stock has a 52-week high of $38.25 and a 52-week low of $2.70.

Read Also: Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics

How To Buy QNTM Stock

By now you're likely curious about how to participate in the market for Quantum BioPharma — be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

Image: Shutterstock